News | Cardiovascular Business | July 27, 2018

ECRI Institute Announces New Clinical Guideline Repository Website

Nonprofit will provide healthcare professionals with new resource for evidence-based clinical guidelines following deactivation of National Guideline Clearinghouse by the federal government in mid-July

ECRI Institute Announces New Clinical Guideline Repository Website

July 27, 2018 — Following the deactivation of the National Guideline Clearinghouse (NGC) by the Agency for Healthcare Research and Quality (AHRQ), the ECRI Institute announced that it will continue providing a centralized source for evidence-based information on clinical practice guidelines.

“ECRI Institute’s team of highly trained guideline and measure experts are taking the lead to ensure the global healthcare community has access to guidelines,” said Karen M. Schoelles, M.D., SM, FACP, director, ECRI Institute-Penn Medicine Evidence-based Practice Center and director, Health Technology Assessment Consulting Services, ECRI Institute.

ECRI Institute’s new guideline resource will provide a centralized repository of current, properly vetted evidence-based clinical practice guideline summaries and other information. An interim website will launch this fall, with many additional features planned for the near future.

The initial site will enable users to search and retrieve ECRI’s summarizations of clinical practice guidelines from hundreds of participating guideline developers. It will include unbiased evaluations on the rigor and transparency of guidelines against the National Academy of Medicine (formerly the Institute of Medicine) standards for trustworthiness.

“Not all guidelines are created equal. Clinicians want to know what stands behind a particular recommendation, and whether they can trust that recommendation,” said Jane Jue, M.D., MSc, medical director, ECRI Institute. “Trustworthy guidance is the real value that we will be providing.”

The second phase will feature advanced search capabilities, support for guideline implementation and decision-making, and an enhanced user interface.

Participating guideline developers will be able to access and contribute to the website free of charge.

For more information: www.ecri.org/guidelines


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now